
    
      Womens presenting with regular menstrual migraine treated with triptans will be included in
      the study. Self-measure of ICP will be performed outside and during menstrual migraine
      attacks. The potential variations will be compared to the measures done on matched healthy
      women outside and during menses.
    
  